• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000070 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2020-03-05 默克雪兰诺有限公司 Merck Serono Co Ltd Filed 2020-03-26 view
JXSL0700003 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products(7) Import Drug Application 2007-01-24 雪兰诺欧洲公司 Merck Serono Europe Ltd Certificate Issued 2008-09-16 view
JYSB1900103 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2019-05-05 默克雪兰诺有限公司 Merck Serono Co Ltd Filed 2019-05-15 view
JYSB2200089 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2022-05-31 view
JYSB1300147 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2013-07-01 默克雪兰诺(北京)医药研发有限公司 Merck Serono (Beijing) Pharmaceutical R&D Co Ltd Certificate Issued 2014-06-06 view
JYSB2000376 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2020-08-21 默克雪兰诺有限公司 Merck Serono Co Ltd Filed 2020-09-02 view
JYSZ1800022 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products License Renew 2018-03-23 默克雪兰诺有限公司 Merck Serono Co Ltd Certificate Issued 2018-10-22 view
JYSB2000315 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2020-07-17 默克雪兰诺有限公司 Merck Serono Co Ltd In Review 2020-07-16 view
JYSB1200031 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2012-03-06 默克雪兰诺(北京)医药研发有限公司 Merck Serono (Beijing) Pharmaceutical R&D Co Ltd Certificate Issued 2015-01-08 view
CXSL2400176 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products(3.3) New Drug Application 2024-03-12 Suzhou Shengji Pharmaceutical Co Ltd view
JYSB1700132 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2017-07-21 默克雪兰诺有限公司 Merck Serono Co Ltd Certificate Issued 2018-10-24 view
JYSB2000069 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products Supplementary Application 2020-03-20 默克雪兰诺有限公司 Merck Serono Co Ltd Certificate Issued 2020-06-05 view
JYSZ2300014 重组人绒促性素注射液 Recombinant Human Choriogonadotropin alfa Injection Biological Products License Renew 2023-03-28 view
CYHB1701472 绒促性素 chorionic gonadotrophin Active ingredient Chemical Drugs Supplementary Application 2017-05-10 上海天伟生物制药有限公司 Shanghai Techwell Biopharmaceutical Co Ltd In Review 2017-05-08 view
CYHS0700663 绒促性素 chorionic gonadotrophin Active ingredient Chemical Drugs(6) Generic Drug 2007-10-25 上海枫华制药有限公司 Shanghai Fenghua Pharmaceutical Co Ltd Certificate Issued 2009-09-03 view
CYHS1000007 绒促性素 chorionic gonadotrophin Active ingredient Chemical Drugs(6) Generic Drug 2010-09-15 上海枫华制药有限公司 Shanghai Fenghua Pharmaceutical Co Ltd Certificate Issued 2012-04-18 view
Y0403460 绒促性素 chorionic gonadotrophin Active ingredient Chemical Drugs(6) Generic Drug 2004-05-31 辽宁卫星制药厂(有限责任公司) Liaoning Satellite Pharmaceutical Factory (Limited Liability Company) Certificate Issued 2004-11-22 view
CYHR1200020 绒促性素 chorionic gonadotrophin Active ingredient Chemical Drugs State Standards 2012-06-29 上海枫华制药有限公司 Shanghai Fenghua Pharmaceutical Co Ltd Certificate Issued 2013-03-27 view
CYHB0500383 绒促性素 chorionic gonadotrophin Active ingredient Chemical Drugs Supplementary Application 2005-03-13 广东天普生化医药股份有限公司 Techpool BIO-PHARMA Co Ltd Certificate Issued 2005-07-22 view
Y0410299 绒促性素 chorionic gonadotrophin Active ingredient Chemical Drugs(6) Generic Drug 2004-09-13 上海天伟生物制药有限公司 Shanghai Techwell Biopharmaceutical Co Ltd Certificate Issued 2005-02-23 view